Since 1998, Wellington Partners has been helping outstanding entrepreneurs to turn their ideas into a reality and to become global leaders in their field of business. As a venture capital firm, we focus on early- and growth-stage life science companies from Germany, Europe and beyond, with breakthrough and truly innovative technologies. With a highly experienced team, a strong track record and a strongly diversified portfolio, we enable entrepreneurial vision and help to unlock potential.
58
life science investments
€590
raised for life science funds
27
life science exits, IPOs & trade sales
Latest News
INVENTION & GROWTH
Funds & Investors
We are currently investing out of our fifth fund – our largest so far – which was considerably oversubscribed at its closing. Its size is more than double the volume of its predecessor. Thus, substantially funded, we have again been able to back the growth ambitions of some of Europe’s most outstanding start-ups in the sector so far.
Name
WPLS V
Investments
15
Volume
EUR 210m
Scope
Bio- & Med Tec
Together we grow:Our portfolio companies are our top priority.
Quanta
Transforming the management in chronic kidney failure
Immatics
Developing novel immunotherapies against solid tumours
Sidekick
Digital care for patients suffering from chronic illnesses
Seamless Therapeutics
Unlocking the full potential of recombinases in gene editing
"I enjoy working with people that are willing to drive change from the status quo."
— Dr. Johannes Fischer, Partner
"The development of products with the potential to help thousands or millions of patients is addictive."
— Dr. Rainer Strohmenger, Managing Partner
"What motivates me every day: Growing Wellington Partners by working with great minds translating great innovation into great product opportunities to shape the future of health care!"
— Dr. Regina Hodits, Managing Partner
"Wellington has given me the opportunity to work in a team where everyone is working towards one goal – how to transform the next big innovative idea into medical practice of tomorrow."
— Dr. Varun Gupta, Partner